The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

The FDA has approved the first-ever Wegovy pill for weight loss, with the oral GLP-1 offering a 16.6% average weight ...

U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily ...

The FDA has approved a pill form of the popular GLP-1 weight-loss medication Wegovy. Novo Nordisk says it is as effective as ...

On Monday evening, the Food and Drug Administration approved Novo Nordisk’s high-dose oral formulation of semaglutide for ...

The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy.

LONDON, Dec 23 (Reuters) - Novo Nordisk's (NOVOb.CO) newly approved weight-loss pill version of Wegovy will be a test case ...

Novo Nordisk shares jumped nearly 8% on Tuesday after the U.S. Food and Drug Administration approved its weight-loss pill, ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, ...

In the studies the company submitted to the FDA, people who took the daily Wegovy pill lost about the same amount of ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

A pill version of weight-loss drug Wegovy will be manufactured in the Triangle and could be available within weeks after the ...